Hanno Hock

Years Active: 2019-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Valentina Nardi, Steven L McAfee, Paola Dal Cin, Harrison K Tsai, Philip C Amrein, Gabriela S Hobbs, Andrew M Brunner, Rupa Narayan, Julia Foster, Amir T Fathi, Hanno Hock
Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy. The oncologist 27 (2) (2022)
Vinayak Venkataraman, Keagan S Casey, Maristela Onozato, Paola Dal Cin, Valentina Nardi, Philip C Amrein, Meghan K Bergeron, Andrew M Brunner, Amir T Fathi, Julia E Foster, Jenna Moran, Timothy A Graubert, Hanno Hock, Chrisa Hunnewell, Matthew J Frigault, Steven McAfee, Gabriela S Hobbs
Long: molecular tracking of CML with bilineal inv(16) myeloid and del(9) lymphoid blast crisis and durable response to CD19-directed CAR-T therapy. Leukemia 34 (11) (2020)
Justin Brumbaugh, Ik Soo Kim, Fei Ji, Aaron J Huebner, Bruno Di Stefano, Benjamin A Schwarz, Jocelyn Charlton, Amy Coffey, Jiho Choi, Ryan M Walsh, Jeffrey W Schindler, Anthony Anselmo, Alexander Meissner, Ruslan I Sadreyev, Bradley E Bernstein, Hanno Hock, Konrad Hochedlinger
Inducible histone K-to-M mutations are dynamic tools to probe the physiological role of site-specific histone methylation in vitro and in vivo. Nature cell biology 21 (11) (2019)

Hanno Hock.css-eqlu8i{font-size:small;padding-left:4px;}